- Research works
- 69 ▲ 125% vs 2013–17
- Citations
- 2k 28.6 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: 1928 Diagnostics (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.3×
- Immunology and Microbiology 6.1×
- Veterinary 5.9×
- Dentistry 3.3×
- Medicine 2.5×
- Engineering 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Health Professions 0.4×
- Environmental Science 0.2×
- Economics, Econometrics and Finance 0.0×
- Agricultural and Biological Sciences 0.0×
Which keywords describe research at 1928 Diagnostics (Sweden)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Tumor Microenvironment, Angiogenesis, PET Imaging, Inflammation, Cancer, Fc Receptors and Therapeutic Antibodies.
- Gene Expression
- Therapeutic Antibodies
- Fibroblast Activation Protein
- Cancer
- PET Imaging
- Tumor Microenvironment
- Cancer Therapy
- Angiogenesis
- Inflammation
- Fc Receptors
- Immunosuppression
- Epidemiology
- Targeted Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 13 words, with their numbers
- Cancer Therapy3▲ 23×4 topics
- Tumor Microenvironment3▲ 29×3 topics
- Angiogenesis2▲ 36×3 topics
- PET Imaging2▲ 67×3 topics
- Inflammation2▲ 5.4×9 topics
- Cancer2▲ 6.9×6 topics
- Fc Receptors2▲ 150×1 topic
- Fibroblast Activation Protein2▲ 185×1 topic
- Immunosuppression2▲ 90×1 topic
- Therapeutic Antibodies2▲ 118×1 topic
- Epidemiology1▲ 1.44×9 topics
- Gene Expression1▲ 8.8×3 topics
- Targeted Therapy1▲ 24×2 topics
Which research topics does 1928 Diagnostics (Sweden) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, Advanced Biosensing Techniques and Applications and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Peptidase Inhibition and Analysis Oncology 2 works
- 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Molecular Biology Techniques and Applications Molecular Biology 1 works
- 6 Cell Adhesion Molecules Research Immunology and Allergy 1 works
- 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 8 Cancer Genomics and Diagnostics Cancer Research 1 works
- 9 CAR-T cell therapy research Oncology 0 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has 1928 Diagnostics (Sweden)'s research output changed?
Output in 2018–2022 was 125% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gothenburg
- University of Gothenburg
- Chalmers University of Technology
- Sahlgrenska University Hospital
- Göteborgs Stads
- RISE Research Institutes of Sweden
- Volvo (Sweden)
- Nordic School of Public Health
- Public Dental Service Västra Götaland
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.